Skip to main content
Erschienen in: Clinical Research in Cardiology 8/2015

01.08.2015 | Original Paper

Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons

verfasst von: Christoph Ohlmeier, Rafael Mikolajczyk, Johann Frick, Franziska Prütz, Wilhelm Haverkamp, Edeltraut Garbe

Erschienen in: Clinical Research in Cardiology | Ausgabe 8/2015

Einloggen, um Zugang zu erhalten

Abstract

Aims

Heart failure (HF) continues to be a leading cause of morbidity and mortality in industrialized countries. Data on the epidemiology of HF are largely lacking for Germany. The aims of this study were to estimate the incidence and prevalence of HF in Germany, to estimate 1-year all-cause mortality in patients who received their first diagnosis of HF in hospital and to assess related risk factors.

Methods

The study was based on data for the years 2004–2006 from three German statutory health insurance providers, comprising data of more than six million people. The study sample was not restricted to a specific age group. The incidence rate of HF in 2006 was assessed in patients who did not have a diagnosis of HF or had not received medications for HF in the previous 2 years. One-year all-cause mortality in patients who received their first diagnosis of HF in hospital was analysed using Kaplan–Meier method and Cox proportional hazard model. Case identification was based on confirmed outpatient diagnoses, main and secondary hospital discharge diagnoses as well as medications for HF.

Results

The age- and sex-standardized incidence rate of HF was 2.7 per 1000 person years. Age- and sex-standardized prevalence of HF was 1.7 % in 2004, 1.9 % in 2005 and 1.7 % in 2006. The 1-year all-cause mortality was 23 % among patients who received their first HF diagnosis during a hospitalization in 2006.

Conclusion

Our study revealed an incidence and prevalence of HF in Germany which were largely comparable to those from other countries. Due to the poor prognosis of HF, high readmission rates and an aging society, HF remains highly relevant in the context of health care planning.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Zarrinkoub R, Wettermark B, Wandell P, Mejhert M, Szulkin R, Ljunggren G, Kahan T (2013) The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. Eur J Heart Fail 15(9):995–1002PubMedCrossRef Zarrinkoub R, Wettermark B, Wandell P, Mejhert M, Szulkin R, Ljunggren G, Kahan T (2013) The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. Eur J Heart Fail 15(9):995–1002PubMedCrossRef
4.
Zurück zum Zitat Gerste B, Günster C, Heller G, Hilfer S (2007) Sektorenübergreifende Leistungsanalysen. Inanspruchnahme von Gesundheitsleistungen durch Patienten mit koronarer Herzkrankheit und Herzinsuffizienz, Bonn Gerste B, Günster C, Heller G, Hilfer S (2007) Sektorenübergreifende Leistungsanalysen. Inanspruchnahme von Gesundheitsleistungen durch Patienten mit koronarer Herzkrankheit und Herzinsuffizienz, Bonn
5.
Zurück zum Zitat Hoffmann F, Icks A (2012) Structural differences between health insurance funds and their impact on health services research: results from the Bertelsmann Health-Care Monitor. Gesundheitswesen 74(5):291–297PubMedCrossRef Hoffmann F, Icks A (2012) Structural differences between health insurance funds and their impact on health services research: results from the Bertelsmann Health-Care Monitor. Gesundheitswesen 74(5):291–297PubMedCrossRef
6.
Zurück zum Zitat Statistisches Bundesamt (2011) Gesundheit: Diagnosedaten der Patienten und Patientinnen in Krankenhäusern, Wiesbaden Statistisches Bundesamt (2011) Gesundheit: Diagnosedaten der Patienten und Patientinnen in Krankenhäusern, Wiesbaden
7.
Zurück zum Zitat Statistisches Bundesamt (2010) Gesundheit: Krankheitskosten, 2002, 2004, 2006 and 2008, Wiesbaden Statistisches Bundesamt (2010) Gesundheit: Krankheitskosten, 2002, 2004, 2006 and 2008, Wiesbaden
8.
Zurück zum Zitat Cleland JG, Gemmell I, Khand A, Boddy A (1999) Is the prognosis of heart failure improving? Eur J Heart Fail 1(3):229–241PubMedCrossRef Cleland JG, Gemmell I, Khand A, Boddy A (1999) Is the prognosis of heart failure improving? Eur J Heart Fail 1(3):229–241PubMedCrossRef
9.
Zurück zum Zitat Blackledge HM, Tomlinson J, Squire IB (2003) Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993–2001. Heart 89(6):615–620PubMedCentralPubMedCrossRef Blackledge HM, Tomlinson J, Squire IB (2003) Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993–2001. Heart 89(6):615–620PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Jong P, Vowinckel E, Liu PP, Gong Y, Tu JV (2002) Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med 162(15):1689–1694PubMedCrossRef Jong P, Vowinckel E, Liu PP, Gong Y, Tu JV (2002) Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med 162(15):1689–1694PubMedCrossRef
11.
Zurück zum Zitat MacIntyre K, Capewell S, Stewart S, Chalmers JW, Boyd J, Finlayson A, Redpath A, Pell JP, McMurray JJ (2000) Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation 102(10):1126–1131PubMedCrossRef MacIntyre K, Capewell S, Stewart S, Chalmers JW, Boyd J, Finlayson A, Redpath A, Pell JP, McMurray JJ (2000) Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation 102(10):1126–1131PubMedCrossRef
12.
Zurück zum Zitat Garbe E, Suling M, Kloss S, Lindemann C, Schmid U (2011) Linkage of mother-baby pairs in the German pharmacoepidemiological research database. Pharmacoepidemiol Drug Saf 20(3):258–264PubMedCrossRef Garbe E, Suling M, Kloss S, Lindemann C, Schmid U (2011) Linkage of mother-baby pairs in the German pharmacoepidemiological research database. Pharmacoepidemiol Drug Saf 20(3):258–264PubMedCrossRef
13.
Zurück zum Zitat Pigeot I, Ahrens W (2008) Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations. Pharmacoepidemiol Drug Saf 17(3):215–223PubMedCrossRef Pigeot I, Ahrens W (2008) Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations. Pharmacoepidemiol Drug Saf 17(3):215–223PubMedCrossRef
15.
Zurück zum Zitat Daly LE (1998) Confidence limits made easy: interval estimation using a substitution method. Am J Epidemiol 147(8):783–790PubMedCrossRef Daly LE (1998) Confidence limits made easy: interval estimation using a substitution method. Am J Epidemiol 147(8):783–790PubMedCrossRef
16.
Zurück zum Zitat Newcombe R, Altman D (2000) Proportions and their differences. In: Altman D, Machin D, Bryant T, Gardner M (eds) Statistics with confidence. British Medical Journal Books, Bristol, pp 45–56 Newcombe R, Altman D (2000) Proportions and their differences. In: Altman D, Machin D, Bryant T, Gardner M (eds) Statistics with confidence. British Medical Journal Books, Bristol, pp 45–56
17.
Zurück zum Zitat International Agency for Research on Cancer (1976) Cancer incidence in five continents. Volume IIV, Lyon International Agency for Research on Cancer (1976) Cancer incidence in five continents. Volume IIV, Lyon
18.
Zurück zum Zitat Fay MP, Feuer EJ (1997) Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med 16(7):791–801PubMedCrossRef Fay MP, Feuer EJ (1997) Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med 16(7):791–801PubMedCrossRef
19.
Zurück zum Zitat Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JC, Stricker BH (2004) Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 25(18):1614–1619PubMedCrossRef Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JC, Stricker BH (2004) Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 25(18):1614–1619PubMedCrossRef
20.
Zurück zum Zitat Cowie MR, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Suresh V, Sutton GC (1999) Incidence and aetiology of heart failure; a population-based study. Eur Heart J 20(6):421–428PubMedCrossRef Cowie MR, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Suresh V, Sutton GC (1999) Incidence and aetiology of heart failure; a population-based study. Eur Heart J 20(6):421–428PubMedCrossRef
21.
Zurück zum Zitat Regitz-Zagrosek V, Oertelt-Prigione S, Seeland U, Hetzer R (2010) Sex and gender differences in myocardial hypertrophy and heart failure. Circ J 74(7):1265–1273PubMedCrossRef Regitz-Zagrosek V, Oertelt-Prigione S, Seeland U, Hetzer R (2010) Sex and gender differences in myocardial hypertrophy and heart failure. Circ J 74(7):1265–1273PubMedCrossRef
22.
Zurück zum Zitat Leong KT, Goh PP, Chang BC, Lingamanaicker J (2007) Heart failure cohort in Singapore with defined criteria: clinical characteristics and prognosis in a multi-ethnic hospital-based cohort in Singapore. Singap Med J 48(5):408–414 Leong KT, Goh PP, Chang BC, Lingamanaicker J (2007) Heart failure cohort in Singapore with defined criteria: clinical characteristics and prognosis in a multi-ethnic hospital-based cohort in Singapore. Singap Med J 48(5):408–414
23.
Zurück zum Zitat Cleland JG, McDonagh T, Rigby AS, Yassin A, Whittaker T, Dargie HJ, National Heart Failure Audit Team for E, Wales (2011) The national heart failure audit for England and Wales 2008–2009. Heart 97(11):876–886 Cleland JG, McDonagh T, Rigby AS, Yassin A, Whittaker T, Dargie HJ, National Heart Failure Audit Team for E, Wales (2011) The national heart failure audit for England and Wales 2008–2009. Heart 97(11):876–886
24.
Zurück zum Zitat Khand AU, Shaw M, Gemmel I, Cleland JG (2005) Do discharge codes underestimate hospitalisation due to heart failure? Validation study of hospital discharge coding for heart failure. Eur J Heart Fail 7(5):792–797PubMedCrossRef Khand AU, Shaw M, Gemmel I, Cleland JG (2005) Do discharge codes underestimate hospitalisation due to heart failure? Validation study of hospital discharge coding for heart failure. Eur J Heart Fail 7(5):792–797PubMedCrossRef
25.
Zurück zum Zitat Schink T, Garbe E (2010) Assessment of the representativity of in-patient hospital diagnoses in the German Pharmacoepidemiological Research Database. Pharmacoepidemiol Drug Saf 19:S178–S179 Schink T, Garbe E (2010) Assessment of the representativity of in-patient hospital diagnoses in the German Pharmacoepidemiological Research Database. Pharmacoepidemiol Drug Saf 19:S178–S179
26.
Zurück zum Zitat Schink T, Garbe E (2010) Representativity of dispensations of non-steroidal anti-inflammatory drugs (NSAIDs) in the German Pharmacoepidemiological Research Database. Pharmacoepidemiol Drug Saf 19:S294 Schink T, Garbe E (2010) Representativity of dispensations of non-steroidal anti-inflammatory drugs (NSAIDs) in the German Pharmacoepidemiological Research Database. Pharmacoepidemiol Drug Saf 19:S294
27.
Zurück zum Zitat Ohlmeier C, Schmedt N, Hillebrand K, Langner I, Mikolajczyk R, Garbe E (2013) Validation of mortality related information in the German Pharmacoepidemiological Research Database (GePaRD). Pharmacoepidemiol Drug Saf 22(S1):306 Ohlmeier C, Schmedt N, Hillebrand K, Langner I, Mikolajczyk R, Garbe E (2013) Validation of mortality related information in the German Pharmacoepidemiological Research Database (GePaRD). Pharmacoepidemiol Drug Saf 22(S1):306
Metadaten
Titel
Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons
verfasst von
Christoph Ohlmeier
Rafael Mikolajczyk
Johann Frick
Franziska Prütz
Wilhelm Haverkamp
Edeltraut Garbe
Publikationsdatum
01.08.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 8/2015
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-015-0841-4

Weitere Artikel der Ausgabe 8/2015

Clinical Research in Cardiology 8/2015 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.